The current clinical aspects of idiopathic portal hypertension

Intractable and Rare Diseases Research

Volumn 2, Issue 3, 2013, Pages 94-97

  Tanaka, Tomohiro ^a   Sugawara, Yasuhiko ^b   Kokudo, Norihiro ^b  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Idiopathic noncirrhotic portal hypertension; Idiopathic portal hypertension (IPH); nodular regenerative hyperplasia (NRH); non cirrhotic portal fibrosis

Indexed keywords

EID: 84995947557     PISSN: 21863644     EISSN: 2186361x     Source Type: Journal    
DOI: 10.5582/irdr.2013.v2.3.94     Document Type: Article

References (42)

1. Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology. 2008; 134:1715-1728.
2. Boyer JL, Sen Gupta KP, Biswas SK, Pal NC, Basu Mallick KC, Iber FL, Basu A.K. Idiopathic portal hypertension. Comparison with the portal hypertension of cirrhosis and extrahepatic portal vein obstruction. Ann Intern Med. 1967; 66:41-68.
3. Sawada S, Sato Y, Aoyama H, Harada K, Nakanuma Y. Pathological study of idiopathic portal hypertension with an emphasis on cause of death based on records of Annuals of Pathological Autopsy Cases in Japan. J Gastroenterol Hepatol. 2007; 22:204-209.
4. Mikkelsen WP, Edmondson HA, Peters RL, Redeker AG, Reynolds T.B. Extra-and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis). Ann Surg. 1965; 162:602-620.
5. Schouten JN, Garcia-Pagan JC, Valla DC, Janssen H.L. Idiopathic noncirrhotic portal hypertension. Hepatology. 2011; 54:1071-1081.
6. Sarin SK, Kapoor D. Non-cirrhotic portal fibrosis: Current concepts and management. J Gastroenterol Hepatol. 2002; 17:526-534.
7. Sama SK, Bhargava S, Nath NG, Talwar JR, Nayak NC, Tandon BN, Wig K.L. Noncirrhotic portal fibrosis. Am J Med. 1971; 51:160-169.
8. Hillaire S, Bonte E, Denninger MH, Casadevall N, Cadranel JF, Lebrec D, Valla D, Degott C. Idiopathic noncirrhotic intrahepatic portal hypertension in the West: A re-evaluation in 28 patients. Gut. 2002; 51:275-280.
9. Matsutani S, Maruyama H, Akiike T, Kobayashi S, Yoshizumi H, Okugawa H, Fukuzawa T, Kimura K, Saisho H. Study of portal vein thrombosis in patients with idiopathic portal hypertension in Japan. Liver Int. 2005; 25:978-983.
10. Nakanuma Y, Nonomura A, Hayashi M, et al. Pathology of the liver in “idiopathic portal hypertension” associated with autoimmune disease. The Ministry of Health and Welfare Disorders of Portal Circulation Research Committee. Acta Pathol Jpn. 1989; 39:586-592.
11. Saito K, Nakanuma Y, Takegoshi K, Ohta G, Obata Y, Okuda K, Kameda H. Non-specific immunological abnormalities and association of autoimmune diseases in idiopathic portal hypertension. A study by questionnaire. Hepatogastroenterology. 1993; 40:163-166.
12. Tsuneyama K, Harada K, Katayanagi K, Watanabe K, Kurumaya H, Minato H, Nakanuma Y. Overlap of idiopathic portal hypertension and scleroderma: Report of two autopsy cases and a review of literature. J Gastroenterol Hepatol. 2002; 17:217-223.
13. Terada T, Nakanuma Y, Obata H. HLA-DR expression on the microvasculature of portal tracts in idiopathic portal hypertension. Immunohistochemical characteristics and relation to portal phlebosclerosis. Arch Pathol Lab Med. 1991; 115:993-997.
14. Yamaguchi N, Tokushige K, Haruta I, Yamauchi K, Hayashi N. Analysis of adhesion molecules in patients with idiopathic portal hypertension. J Gastroenterol Hepatol. 1999; 14:364-369.
15. Sarin S.K. Non-cirrhotic portal fibrosis. Gut. 1989; 30:406-415.
16. Kono K, Ohnishi K, Omata M, Saito M, Nakayama T, Hatano H, Nakajima Y, Sugita S, Okuda K. Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits. Gastroenterology. 1988; 94:787-796.
17. Sarin SK, Mehra NK, Agarwal A, Malhotra V, Anand BS, Taneja V. Familial aggregation in noncirrhotic portal fibrosis: A report of four families. Am J Gastroenterol. 1987; 82:1130-1133.
18. Barnett JL, Appelman HD, Moseley R.H. A familial form of incomplete septal cirrhosis. Gastroenterology. 1992; 102:674-678.
19. Schwarzler P, Carvalho JS, Senat MV, Masroor T, Campbell S, Ville Y. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population. Br J Obstet Gynaecol. 1999; 106:1029-1034.
20. Girard M, Amiel J, Fabre M, Pariente D, Lyonnet S, Jacquemin E. Adams-Oliver syndrome and hepatoportal sclerosis: Occasional association or common mechanism? Am J Med Genet A. 2005; 135:186-189.
21. Roulot D, Degott C, Chazouillères O, Oberti F, Calès P, Carbonell N, Benferhat S, Bresson-Hadni S, Valla D. Vascular involvement of the liver in Turner's syndrome. Hepatology. 2004; 39:239-247.
22. Krasinskas AM, Eghtesad B, Kamath PS, Demetris AJ, Abraham S.C. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl. 2005; 11:627-634; discussion 610-611.
23. Dhiman RK, Chawla Y, Vasishta RK, Kakkar N, Dilawari JB, Trehan MS, Puri P, Mitra SK, Suri S. Noncirrhotic portal fibrosis (idiopathic portal hypertension): Experience with 151 patients and a review of the literature. J Gastroenterol Hepatol. 2002; 17:6-16.
24. Nakanuma Y, Hoso M, Sasaki M, Terada T, Katayanagi K, Nonomura A, Kurumaya H, Harada A, Obata H. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology. 1996; 28:195-204.
25. Ludwig J, Hashimoto E, Obata H, Baldus W.P. Idiopathic portal hypertension; A histopathological study of 26 Japanese cases. Histopathology. 1993; 22:227-234.
26. Schouten JN, Nevens F, Hansen B, Laleman W, van den Born M, Komuta M, Roskams T, Verheij J, Janssen H.L. Idiopathic noncirrhotic portal hypertension is associated with poor survival: Results of a long-term cohort study. Aliment Pharmacol Ther. 2012; 35:1424-1433.
27. Okuda K, Kono K, Ohnishi K, et al. Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology. 1984; 86:600-610.
28. Nevens F, Staessen D, Sciot R, Van Damme B, Desmet V, Fevery J, De Groote J, Van Steenbergen W. Clinical aspects of incomplete septal cirrhosis in comparison with macronodular cirrhosis. Gastroenterology. 1994; 106:459-463.
29. Ichimura S, Sasaki R, Takemura Y, Iwata H, Obata H, Okuda H, Imai F. The prognosis of idiopathic portal hypertension in Japan. Intern Med. 1993; 32:441-444.
30. Eapen CE, Nightingale P, Hubscher SG, Lane PJ, Plant T, Velissaris D, Elias E. Non-cirrhotic intrahepatic portal hypertension: Associated gut diseases and prognostic factors. Dig Dis Sci. 2011; 56:227-235.
31. Cazals-Hatem D, Hillaire S, Rudler M, Plessier A, Paradis V, Condat B, Francoz C, Denninger MH, Durand F, Bedossa P, Valla D.C. Obliterative portal venopathy: Portal hypertension is not always present at diagnosis. J Hepatol. 2011; 54:455-461.
32. Nakanuma Y, Tsuneyama K, Ohbu M, Katayanagi K. Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract. 2001; 197:65-76.
33. Sarin SK, Aggarwal S.R. Idiopathic portal hypertension. Digestion. 1998; 59:420-423.
34. Chawla YK, Dilawari JB, Dhiman RK, Goenka MK, Bhasin DK, Kochhar R, Singh K, Kaur U. Sclerotherapy in noncirrhotic portal fibrosis. Dig Dis Sci. 1997; 42:1449-1453.
35. de Franchis R; Baveno V Faculty. Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010; 53:762-768.
36. Bari K, Garcia-Tsao G. Treatment of portal hypertension. World J Gastroenterol. 2012; 18:1166-1175.
37. Segawa M, Sakaida I. Diagnosis and treatment of portal hypertension. Hepatol Res. 2009; 39:1039-1043.
38. Sarin SK, Wadhawan M, Gupta R, Shahi H. Evaluation of endoscopic variceal ligation (EVL) versus propanololplus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: Comparison of cirrhotic and noncirrhotic patients. Dig Dis Sci. 2005; 50:1538-1547.
39. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana U.K. Prevalence, classification and natural history of gastric varices: A long-term follow-up study in 568 portal hypertension patients. Hepatology. 1992; 16:1343-1349.
40. Hosking SW, Kennedy HJ, Seddon I, Triger D.R. The role of propranolol in congestive gastropathy of portal hypertension. Hepatology. 1987; 7:437-441.
41. Hirota S, Ichikawa S, Matsumoto S, Motohara T, Fukuda T, Yoshikawa T. Interventional radiologic treatment for idiopathic portal hypertension. Cardiovasc Intervent Radiol. 1999; 22:311-314.
42. Yoshida H, Mamada Y, Taniai N, Tajiri T. New trends in surgical treatment for portal hypertension. Hepatol Res. 2009; 39:1044-1051.